TOPIC

BIG PHARMA News & Analysis

24 stocks for 2030
Stocks
24 stocks for 2030
Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.
Susan Dziubinski | 01 October 2020
Three vaccines capable of US authorisation in 2020
Stocks
Three vaccines capable of US authorisation in 2020
We expect most US adults will be vaccinated in the first half of 2021, writes Morningstar healthcare strategist Karen Andersen.
Karen Andersen, CFA | 01 September 2020
4 healthcare stocks attractive on valuation and ESG risk
Video
4 healthcare stocks attractive on valuation and ESG risk
Morningstar's Karen Andersen explains how environmental, social and governance issues affect Big Pharma and biotech companies.
Karen Andersen, CFA | 10 February 2020